Clinical Performance of 59% Hioxifilcon A vs. Marketed Hydrogel Contact Lenses in Habitual Hydrogel Wearers
Launched by VISION SERVICE PLAN · Jul 22, 2021
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
This randomized clinical trial will compare the short-term clinical performance, and wearer acceptability of a new-to-market hioxifilcon A spherical daily DD contact lenses against marketed DD lenses in a short cross-over clinical trial.
The primary outcome variable for this study is overall subjective comfort.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Currently wearing hydrogel, spherical DD contact lenses at least 5 days/week
- • Vision correctable to 20/30 acuity in each eye with spherical DD contact lenses
- • No ocular or systemic disease that contra-indicates soft contact lens wear
- Exclusion Criteria:
- • Currently wearing silicone hydrogel DD contact lenses
- • Currently wearing 1-DAY ACUVUE® MOIST (comparator) contact lenses
- • Currently using rewetting drops with habitual contact lenses
- • Vision not correctable to 20/30
- • Participating in another clinical trial
About Vision Service Plan
Vision Service Plan (VSP) is a leading not-for-profit vision benefits and services organization dedicated to enhancing the eye health and overall well-being of individuals through innovative solutions and comprehensive eye care programs. With a commitment to advancing vision science and improving patient outcomes, VSP actively sponsors clinical trials that explore new treatments and technologies in eye care. By partnering with healthcare professionals and research institutions, VSP aims to contribute valuable insights to the field of optometry and ophthalmology, ultimately promoting better vision health for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Westerville, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials